These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16923971)

  • 41. [A modern method for differential gene expression analysis and its significance for cancer diagnostics and therapy].
    Pospísilová S; Mayer J
    Cas Lek Cesk; 2005; 144(1):11-7; discussion 18. PubMed ID: 15789776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genomic medicine. Gene expression tests foretell breast cancer's future.
    Garber K
    Science; 2004 Mar; 303(5665):1754-5. PubMed ID: 15031473
    [No Abstract]   [Full Text] [Related]  

  • 43. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
    Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
    J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrative oncogenomic analysis of microarray data in hematologic malignancies.
    Martínez-Climent JA; Fontan L; Fresquet V; Robles E; Ortiz M; Rubio A
    Methods Mol Biol; 2010; 576():231-77. PubMed ID: 19882266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer heterogeneity and "the struggle for existence": diagnostic and analytical challenges.
    Horswell S; Matthews N; Swanton C
    Cancer Lett; 2013 Nov; 340(2):220-6. PubMed ID: 23142290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic medicines for oncology: early lessons.
    Simons JW
    J Med Assoc Ga; 2003; 92(1):35-8. PubMed ID: 12743904
    [No Abstract]   [Full Text] [Related]  

  • 47. Genetic profiling can predict chemotherapy side effects and treatment response.
    Expert Rev Mol Diagn; 2003 Jul; 3(4):406-7. PubMed ID: 12877380
    [No Abstract]   [Full Text] [Related]  

  • 48. [Polygenetic pharmacogenomic strategies to identify drug sensitivity biomarkers].
    Nishiyama M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1902-7. PubMed ID: 16282724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microarrays to identify new therapeutic strategies for cancer.
    Sears C; Armstrong SA
    Adv Cancer Res; 2007; 96():51-74. PubMed ID: 17161676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An exploration into study design for biomarker identification: issues and recommendations.
    Hall JA; Brown R; Paul J
    Cancer Genomics Proteomics; 2007; 4(3):111-9. PubMed ID: 17878515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomic medicine and targeted therapy for solid tumors.
    Stevens EA; Rodriguez CP
    J Surg Oncol; 2015 Jan; 111(1):38-42. PubMed ID: 25042935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Understanding genomic alterations in cancer genomes using an integrative network approach.
    Wang E
    Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer omics: from regulatory networks to clinical outcomes.
    Tang B; Hsu PY; Huang TH; Jin VX
    Cancer Lett; 2013 Nov; 340(2):277-83. PubMed ID: 23201140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [MicroRNA and cancer].
    Kiselev FL
    Mol Biol (Mosk); 2014; 48(2):232-42. PubMed ID: 25850292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Individuated molecular target chemotherapy].
    Yamamoto W; Endo W; Sato A; Matsukawa M
    Nihon Rinsho; 2002 Jan; 60(1):168-73. PubMed ID: 11808329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast cancer genomics: real-time use.
    Bertucci F; Birnbaum D
    Lancet Oncol; 2007 Dec; 8(12):1045-1047. PubMed ID: 18054870
    [No Abstract]   [Full Text] [Related]  

  • 57. [Development of the protein microarray technique and usefulness in individualized molecular tumor therapy]].
    Espina V
    Onkologie; 2005 Oct; 28 Suppl 4():40-2. PubMed ID: 16205105
    [No Abstract]   [Full Text] [Related]  

  • 58. [Novel tumor markers-circulating miRNA].
    Xie L; Qian XP; Liu BR
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):641-2. PubMed ID: 22340041
    [No Abstract]   [Full Text] [Related]  

  • 59. Cancer epigenetics as biomarkers of clinical significance.
    Panayiotidis MI
    Cancer Lett; 2014 Jan; 342(2):168-9. PubMed ID: 24183850
    [No Abstract]   [Full Text] [Related]  

  • 60. Researchers hope new database becomes universal cancer genomics tool.
    Martin M
    J Natl Cancer Inst; 2012 Jul; 104(14):1045-7. PubMed ID: 22781431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.